Search    Show all

1 People found

filters applied:


1 / 1

EMBO Member

Bruno Amati

European Institute of Oncology (IEO), Milano | Italy

EMBO 2006 | YipC 11–14

Targeting disease mechanisms in MYC-driven cancer

We study disease mechanisms and therapeutic opportunities in MYC-driven cancers. These tumors show 'oncogene addiction', implying that MYC itself – and presumably a subset of its target genes – are required for tumor maintenance. Moreover, the fitness of MYC-overexpressing cells depends on a fragile equilibrium between conflicting stress signals, providing opportunities to exploit synthetic lethality as a strategy for therapeutic intervention.

Keywords: Oncogenes / Myc / chromatin / transcription / cancer / lymphoma / therapy

Subject area(s): Chromatin & Transcription | Differentiation & Death | Molecular Medicine